Skip to content

Change in AP at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$3.1M+88.1%
Arrowhead Research logo
Arrowhead ResearchARWR
$15.26M+397%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$1.45M-49.4%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$68.71M-471%
Scholar Rock logo
Scholar RockSRRK
-$1.09M+80.8%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$4.05M+24.9%

Other financials

Income statement

See full
Operating income-$125.3M-2.4%
Net income-$120.9M-4.8%
EPS (diluted)-$0.73+30.5%

Balance sheet

See full
Cash & equivalents$753.1M+59.5%
Total debt$168.7M+623%
Total equity$865.1M+29.3%
Total assets$1.1B+49.8%

Cash flow

See full
Operating cash flow-$144.9M-36.9%
CapEx$221.0K-77.5%
Free cash flow-$145.1M-35.8%

Valuation

See full
Market cap$3.35B+153%

Returns & leverage

See full
Return on equity-58.9%-4.4pp
Debt / equity0.2×+0.2×
Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s change in AP?
Dyne Therapeutics, Inc. (DYN) reported change in AP of -$4.8M in Q1 2026.
How has Dyne Therapeutics, Inc.'s change in AP changed year-over-year?
Dyne Therapeutics, Inc.'s change in AP increased by 44.1% year-over-year, from -$8.6M to -$4.8M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.